Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dipna Pharmachem Ltd has informed the BSE that its trading window will remain closed for all Directors, Promoters, Designated Persons and Insiders starting Wednesday, April 1, 2026. The window will stay shut until 48 hours after the company declares and publishes its audited financial results for the financial year ended March 31, 2026. The closure is being done as per SEBI's Insider Trading Regulations and the company's own internal code of conduct. The intimation has been signed by Managing Director Keyur Shah. This is a standard regulatory compliance filing with no new financial information disclosed.
This is a routine compliance filing and should not materially impact the stock price. However, it signals that audited annual results for FY26 are imminent, which investors should watch for as they will contain key performance numbers for the company.